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Abstract
Obesity is a constantly increasing health problem worldwide. It is associated with a sys-
temic low-grade inflammation, which contributes to the development of metabolic disor-
ders and comorbidities such as type 2 diabetes. Diet has an important role in the
prevention of obesity and its adverse health effects; as a part of healthy diet, polyphenol-
rich berries, such as lingonberry (Vaccinium vitis-idaea L.) have been proposed to have
health-promoting effects. In the present study, we investigated the effects of lingonberry
supplementation on high-fat diet induced metabolic and inflammatory changes in a mouse
model of obesity. Thirty male C57BL/6N mice were divided into three groups (n = 10/
group) to receive low-fat (LF), high-fat (HF) and lingonberry-supplemented high-fat (HF
+LGB) diet for six weeks. Low-fat and high-fat diet contained 10% and 46% of energy from
fat, respectively. Lingonberry supplementation prevented the high-fat diet induced adverse
changes in blood cholesterol and glucose levels and had a moderate effect on the weight
and visceral fat gain, which were 26% and 25% lower, respectively, in the lingonberry
group than in the high-fat diet control group. Interestingly, lingonberry supplementation
also restrained the high-fat diet induced increases in the circulating levels of the proinflam-
matory adipocytokine leptin (by 36%) and the inflammatory acute phase reactant serum
amyloid A (SAA; by 85%). Similar beneficial effects were discovered in the hepatic expres-
sion of the inflammatory factors CXCL-14, S100A10 and SAA by lingonberry supplementa-
tion. In conclusion, the present results indicate that lingonberry supplementation
significantly prevents high-fat diet induced metabolic and inflammatory changes in a
murine model of obesity. The results encourage evaluation of lingonberries as a part of
healthy diet against obesity and its comorbidities.
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1. Introduction
The prevalence of obesity, metabolic syndrome and type 2 diabetes has increased rapidly
worldwide during the last decades. Reasons can be found in changing lifestyles, which lead to
reduced physical activity and obesogenic diet. It seems that obesity is continuing to be an
increasing global health burden; according to the WHO statistics, 13% of adults aged 18 and
over (corresponding to over 650 million people) were obese (body mass index BMI > 30 kg/
m2) and 39% overweight in 2016 [1]. Obesity is a complex chronic disorder with a multifacto-
rial etiology, involving genetics, hormones, diet and environment [2], and it has a major
impact on various metabolic and (patho)physiological functions in the human body. Obesity
is a major risk factor and underlying condition in the progression of many metabolic disor-
ders, particularly type 2 diabetes, cardiovascular diseases and cancer, through its effects on the
development of, for instance hypertension, insulin resistance, nonalcoholic fatty liver disease
and inflammation [3,4].
Adipose tissue is an active tissue regulating various physiological and pathological pro-
cesses, including immunity and inflammation. It is therefore no longer considered only as a
passive energy storage. Adipose tissue produces and releases several hormone-like factors
called adipokines, and many of them have pro- or anti-inflammatory properties [2,5]. In obese
adipose tissue, immune cells secreting pro-inflammatory substances increase in number while
those producing anti-inflammatory substances have been shown to decrease. This imbalance
is responsible for the obesity induced low-grade inflammation and insulin resistance in the
body [3].
Diet has an important role in the prevention and treatment of obesity, type 2 diabetes and
other obesity-related diseases. Diets containing plenty of polyphenol-rich vegetables have been
shown to lower the risk of obesity-related comorbidities [6–8]. Berries are specifically rich in
various polyphenols [9,10]. Diets containing berries are associated with lowered risk of type 2
diabetes, probably due to the flavonoids [11], anthocyanidins [8,12,13] or other polyphenols
[14] present in berries. Several intervention studies have shown beneficial effects of berries
also on inflammation and cardiovascular diseases [15].
Lingonberry (Vaccinium vitis-idaea L.) has been reported to have promising health-benefi-
cial effects and anti-inflammatory properties in experimental models [16–19]. Lingonberries /
lingonberry extracts were found to exhibit antidiabetic potential in various in vitro tests [20]
and beneficial metabolic effects in mice exposed to high-fat diet [21–25]. Lingonberries are
rich in dietary polyphenols with high antioxidant activities [16,26–28] and contain also essen-
tial omega-3 fatty acids [29] and plant sterols [30,31], which may contribute to their health-
promoting effects. Lingonberries are commonly consumed in the Nordic countries and com-
mercially available in many different forms. They are also the most generally collected and
commercially utilized wild berries in Finland [32].
In the present study, we aimed to investigate the effects of lingonberry supplementation on
metabolic and inflammatory changes in high-fat diet induced experimental obesity in mice to
extend the current understanding on the health benefits of lingonberries. As the test material,
we used commercially available air-dried lingonberry powder made from Finnish
lingonberries.
2. Materials and methods
Animals and study design
Male C57BL/6N mice (Scanbur Research A/S, Karlslunde, Denmark), 8 weeks of age and 24.3
±0.2g of weight at the beginning of the experiment, were divided into three groups of 10 mice,
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and housed two mice per cage in the animal facility of the Tampere University under standard
conditions (12/12h light/dark cycle, 22±1 ˚C temperature, and 50–60% humidity) with food
and water provided ad libitum.
The mice were fed with normal low-fat diet (LF, 10 kcal% fat), with high-fat diet (HF, 46
kcal% fat) or with high-fat diet supplemented with air-dried lingonberry (Vaccinium vitis-
idaea L.) powder (HF + LGB, 20% w/w) for 6 weeks. Both high-fat diets contained 46% of
energy from fat and 36% from carbohydrate, while the low-fat diet had 10% of energy from fat
and 72% from carbohydrate (Table 1). Otherwise the custom-made pelleted diets (Research
Diets, Inc, New Brunswick, NJ, USA) were matched for protein (18% of energy from protein),
fiber, vitamin and trace element contents considering the composition of the lingonberry pow-
der. Air-dried lingonberry powder (100 g powder corresponds to ca 900 g fresh berries) was
produced from Finnish lingonberries by Kiantama Ltd (Suomussalmi, Finland).
Table 1. Composition of the experimental diets.
LF HF HF+LGB
Calculated energy (kcal)
Protein 716 716 716
Carbohydrate 2840 1422 1422
Starch 2110 691 691
Sugar 730 731 731
Fat 405 1823 1823
Total energy 3961 3961 3961
Calculated energy per gram diet (kcal/g) 3.60 4.39 4.30
Calculated Energy (kcal%)
Protein 18 18 18
Carbohydrate 72 36 36
Fat 10 46 46
Fiber (g%) 9 10 10
Lingonberry powder (g) 0 0 184�
Ingredients (g)
(+ from LGB powder)
Casein 200 200 194 (+ 6) total: 200
L-Cystine 3 3 3
Corn Starch 452 73 31 (+ 42) total: 73
Maltodextrin 10 75 100 100
Sucrose 173 173 103 (+ 70) total: 173
Cellulose 94 94 50 (+ 44) total: 94
Soybean Oil 25 25 24 (+ 1) total: 25
Lard 20 178 178
Mineral Mix S10026 10 10 10
DiCalcium Phosphate 13 13 13
Calcium Carbonate 6 6 6
Potassium Citrate 17 17 17
Vitamin Mix V10001 10 10 10
Choline Bitartrate 2 2 2
LF = low-fat diet, HF = high-fat diet, HF+LGB = lingonberry-supplemented high-fat diet
�Nutrient content/100 g lingonberry powder: fat 0.8 g, carbohydrates 61 g (of which sugars 38 g), fiber 24 g, protein 3
g
https://doi.org/10.1371/journal.pone.0232605.t001
PLOS ONE Beneficial effects of lingonberry (Vaccinium vitis-idaea L.) supplementation in a mouse model of obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0232605 May 7, 2020 3 / 17
Body weight of the mice and food consumption was monitored weekly. At the end of the
study, 6h-fasted mice were anesthetized with isoflurane (Oriola Corp., Espoo, Finland), blood
glucose was measured and blood was collected by cardiac puncture. Tissue samples were col-
lected for further analyses. The study was approved by the National Animal Experimental
Board (permission number ESAVI- 984/04.10.07/2018) and the experiments were carried out
in accordance with the EU legislation for the protection of animals used for scientific purposes
(Directive 2010/63/EU).
Blood samples and analyses
Six-hour fasting (morning fast) blood glucose levels in mice were measured from the tip of the
tail with Contour Next One (Oy Diabet Ab, Lemu, Finland). Blood collected by cardiac punc-
ture was centrifuged for 15 minutes at 1500 x g after 30 minutes incubation at room tempera-
ture, and obtained serum was immediately storaged at -80 ˚C. Serum triglyceride and total
cholesterol levels, and alanine aminotransferase (ALT) activity were measured by fluorometric
assays (Abcam, Cambridge, UK). Enzyme-linked immunoassays were used to measure the
concentrations of leptin, resistin and adiponectin (R&D Systems Europe Ltd., Abingdon, UK),
insulin (Mercodia Ltd., Uppsala, Sweden) and serum amyloid A (Tridelta Development Ltd.,
Maynooth, Ireland) in serum samples. Detection limits were 7.8 pg/mL for leptin and resistin,
15.6 pg/mL for adiponectin, 33 pmol/L for insulin and 16 ng/mL for SAA.
RNA extraction and qRT-PCR
Total RNA was extracted from liver using RNeasy Mini Kit (Qiagen Inc., Hilden, Germany).
Briefly, samples stored immediately after collection in RNA Later1 (Ambion, Thermo Fisher
Scientific, Waltham, MA, USA) were weighed and maximum of 30 mg of tissue was cut into
smaller pieces and homogenized with Qiashredder (Qiagen). RNA was extracted with RNeasy
Mini Kit with on-column DNase digestion. RNA was transcribed to cDNA by using Maxima
First Strand cDNA Synthesis Kit (Thermo Fisher Scientific) in 10 ul reaction volume and
diluted 1:5 with RNase-free water. Quantitative PCR was performed using TaqMan Universal
Master Mix and ABI Prism 7500 sequence detection system (Applied Biosystems, Foster City,
CA, USA). The PCR cycling parameters were incubation at 50 ˚C for 2 minutes, incubation at
95 ˚C for 10 minutes, and thereafter 40 cycles of denaturation at 95 ˚C for 15 s and annealing
and extension at 60 ˚C for 1 minute. Primers and probe for the housekeeping gene glyceralde-
hyde 3-phosphate dehydrogenase GAPDH) were GCATGGCCTTCCGTGTTC (forward, 300
nM), GATGTCATCATACTTGGCAGGTTT (reverse, 300nM) and TCGTGGATCTGACGTG
CCGCC (probe, 150 nM); and TCGGAGGCTTAATTACACATGTTC (forward, 900 nM),
CAAGTGCATCATCGTTGTTCATAC (reverse, 300 nM) and CAGAATTGCCATTGCACAACT
CTTTTCTCA (probe, 200 nM) for interleukin 6 (IL-6). The sequences and concentrations
were optimized according to the manufacturer’s guidelines in TaqMan Universal PCR Master
Mix Protocol part number 4304449 revision C (Applied Biosystems). TaqMan Gene Expres-
sion assays for interleukin 1β (IL-1β, Mm00434228_m1), monocyte chemoattractant protein 1
(MCP-1, Mm00441242_m1), tumor necrosis alpha (TNF-α, Mm00443260_g1), glucose trans-
porter 2 (GLUT2, Mm00446229_m1), serum amyloid A2 (SAA2, Mm04208126_mH), C-X-C
motif chemokine ligand 14 (CXCL-14, Mm00444699_m1), S100 calcium-binding protein A10
(S100A10, Mm00501458_g1), and insulin receptor (Insr, Mm01211875_m1) were used
(Thermo Fisher Scientific) and expression levels were calculated using the 2(−ΔΔCT) method.
When calculating results, all of the mRNA expression levels were first normalized against
GAPDH mRNA levels.
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Statistics
Results are expressed as mean + standard error of mean (SEM). One-way and two-way
ANOVA with Bonferroni’s post-test, and the analysis of covariance were performed using
GraphPad InStat version 3.10 and GraphPad Prism 8 (GraphPad Software, San Diego, USA),
and IBM SPSS Statistics version 25.0 (IBM Corporation, Armonk, NY, USA). Asterisks �, ��,
and ��� indicate p values smaller than 0.05, 0.01 and 0.001, respectively.
3. Results
3.1. Weight gain
The weight of mice in the high-fat (HF) group increased considerably during the study as com-
pared to the mice in the low-fat (LF) control group. Interestingly, lingonberry supplementa-
tion prevented significantly the high-fat diet induced weight gain (p< 0.001 between HF and
HF+LGB groups). After 6 weeks, the average weight of the low-fat group was 28.0±0.4 g, 37.4
±0.6 g in the high-fat group and 34.1±0.6 g in the lingonberry supplemented high-fat group,
respectively (p< 0.001 between groups). The development of weight of the mice in the test
groups is presented in the Fig 1.
The amount of epididymal fat increased in the high-fat diet group, when compared to the
low-fat control group (p< 0.001). Lingonberry supplementation prevented significantly the
accumulation of epididymal fat when compared to the high-fat control group (p< 0.001). At
the end of the study, the amount of epididymal fat was 2.4±0.1 g in the high-fat group and 1.8
±0.1 g in the lingonberry supplemented high-fat group. Both high-fat groups had significantly
Fig 1. Body weight gain of the mice during the study. Animals received low-fat diet (LF diet, 10% of energy from fat,
dark grey line), high-fat diet (HF diet, 46% of energy from fat, black line) or high-fat diet supplemented with
lingonberry (HF + LGB diet, light grey line). Weight was measured once a week. The results are expressed as grams (g).
Values represent mean + SEM, n = 10 mice per group. Repeated measures two-way ANOVA with Bonferroni post-test
was used in the statistical analysis. Mean values significantly different from the high-fat group (HF diet) are marked
with �p< 0.05, ��p< 0.01 and ���p< 0.001.
https://doi.org/10.1371/journal.pone.0232605.g001
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(p< 0.001) higher amount of epididymal fat than the low-fat group (0.9±0.0 g; Fig 2). When
the ratio of the epididymal fat to the whole-body mass was calculated, it was lower in the HF
+LGB group than in the HF group (p< 0.01) suggesting that lingonberry supplementation
prevents particularly the accumulation of the metabolically highly detrimental visceral adipose
tissue. That was also supported by the fact that in the analysis of covariance when the body
weight was set as a covariate, the epididymal fat mass was lower in the LF and the HF+LGB
groups than in the HF group (p< 0.01).
Food consumption (kcal/g body weight) was measured weekly and it did not differ between
the high-fat and the lingonberry supplemented high-fat diet groups although energy intake in
the low-fat diet group was lower, particularly during the first half of the study (Fig 3A). We
also calculated the cumulative food consumption (kcal/g body weight) during the six weeks’
study: no difference was found between the high-fat and the lingonberry supplemented high-
fat groups while the value in the low-fat group was lower (p < 0.01; Fig 3B). This result was
reproduced in repeated measures analysis of covariance with body weight as a covariate.
3.2. Glucose and insulin
Fasting blood glucose level at the end of the study was increased in the high-fat diet group, as
compared to the low-fat control group (p< 0.01). Interestingly, in the lingonberry supple-
mented high-fat diet group, the glucose level (10.0±0.5 mmol/L) was lower than that in the
Fig 2. The amount of epididymal fat of the mice at the end of the study. Animals received low-fat diet (LF diet, 10% energy from
fat, grey column), high-fat diet (HF diet, 46% energy from fat, black column) or high-fat diet supplemented with lingonberry (HF
+ LGB diet, white column). The amount of epididymal fat was measured at the end of the study. The results are expressed as grams
(g). Values represent mean + SEM, n = 10 mice per group. One-way ANOVA with Bonferroni post-test was used in the statistical
analysis. Differences between the groups are marked with ���p< 0.001.
https://doi.org/10.1371/journal.pone.0232605.g002
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high-fat control group (11.2±0.4 mmol/L; p< 0.05), and there was no statistically significant
difference between the low-fat and the lingonberry supplemented high-fat groups (Fig 4).
As expected, fasting insulin level was significantly higher in the high-fat group (156.5 pmol/
L) as compared to the low-fat group (65.5 pmol/L; p< 0.001). In the lingonberry supple-
mented high-fat group, the insulin level (113.7 pmol/L) was lower than in the high-fat group,
although the effect did not reach statistical significance (Fig 5).
3.3. Cholesterol and triglycerides
Cholesterol level was significantly increased in the high-fat group when compared to the low-
fat group (p< 0.001) being 2.6±0.1 mmol/L in the high-fat group and 1.7±0.1 mmol/L in the
low-fat group at the end of the study. Importantly, the cholesterol level in the lingonberry sup-
plemented high-fat group (2.0±0.2 mmol/L) was significantly lower when compared to the
high-fat group (p< 0.01). There was no statistically significant difference in the cholesterol
levels between the low-fat and the lingonberry supplemented high-fat groups indicating that
lingonberry supplementation prevented the high-fat diet induced increase in cholesterol levels
(Fig 6A).
There were no differences in the triglyceride levels between the low-fat and high-fat groups
whereas the triglyceride level in the lingonberry supplemented high-fat group was lower than
that in the two other groups (p< 0.05; Fig 6B).
3.4. Adipokines and inflammatory factors
As expected, leptin levels were significantly higher in the high-fat group as compared to the
low-fat group (p< 0.001). Leptin levels were lower in the lingonberry supplemented high-fat
group (27.1±3.5 ng/mL) than in the high-fat control group (39.7±2.8 ng/mL; p< 0.01,
Fig 3. Food consumption during the study. Fig 3A shows the weekly and Fig 3B the cumulative food consumption during the six weeks’ study.
Animals received low-fat diet (LF diet, 10% energy from fat, grey columns), high-fat diet (HF diet, 46% energy from fat, black columns) or high-fat diet
supplemented with lingonberry (HF + LGB diet, white columns). Food consumption was measured once a week. The results are expressed as kcal/body
weight in grams. Values represent mean + SEM, n = 10 mice per group; as the mice were housed two mice per cage, n = 5 was used in the statistical
calculations. Repeated measures two-way ANOVA (Fig 3A) and one-way ANOVA (Fig 3B) with Bonferroni post-test was used in the statistical analysis.
Differences between the groups are marked with ��p<0.01 and ���p< 0.001.
https://doi.org/10.1371/journal.pone.0232605.g003
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Table 2). Interestingly, the statistically significant difference was also observed in weight-
related values (1.1±0.1 ng/mL/body weight (g) in HF group vs. 0.8±0.1 ng/mL/body weight (g)
in HF+LGB group, p< 0.01). In adiponectin, there was a trend towards decreased levels in the
high-fat group when compared to low-fat control group (p = 0.277). Adiponectin level was
maintained at normal levels with lingonberry supplementation. There were no significant dif-
ferences in the resistin levels between the groups (Table 2).
The levels of the inflammatory acute phase reactant serum amyloid A (SAA) were increased
(p< 0.001) in the high-fat diet group (11.7±0.7 μg/mL) as compared to the low-fat diet group
(6.6±0.6 μg/mL). Importantly, the SAA levels in the lingonberry supplemented high-fat group
(7.4±0.4 μg/mL) were significantly lower (p< 0.001) than those in the high-fat control group.
Similarly, alanine aminotransferase activity was increased in the high-fat diet group as com-
pared to the low-fat diet group (p<0.001) which was prevented by the lingonberry supplemen-
tation (p< 0.001) (Table 2).
High-fat diet is known to induce metabolic and inflammatory changes in the liver. There-
fore, we analyzed the expression of insulin receptor and glucose transporter GLUT2 as well as
the inflammatory factors TNF-α, IL-1β, IL-6, MCP-1, SAA2, CXCL-14 and S100A10 in the
liver by quantitative RT-PCR. As shown in the Fig 7, the hepatic expression of CXCL-14
(p< 0.001), S100A10 (p< 0.05), and SAA2 (p< 0.01) were significantly lower in the lingon-
berry supplemented high-fat diet group than in the high-fat control group, while IL-6 was
under detection limit and no statistically significant differences in the expression of TNF-α,
IL-1β, MCP-1, GLUT2 or insulin receptor were observed between the groups.
Fig 4. The fasting blood glucose levels of mice at the end of the study. Animals received low-fat diet (LF diet, 10%
energy from fat, grey column), high-fat diet (HF diet, 46% energy from fat, black column) or high-fat diet
supplemented with lingonberry (HF + LGB diet, white column). At the end of the study, blood samples for glucose
measurements were collected after 6 h fasting. The results are expressed as mmol/L. Values represent mean + SEM,
n = 10 mice per group. One-way ANOVA with Bonferroni post-test was used in the statistical analysis. Differences
between the groups are marked with �p< 0.05, ��p< 0.01 and ns = not significant.
https://doi.org/10.1371/journal.pone.0232605.g004
PLOS ONE Beneficial effects of lingonberry (Vaccinium vitis-idaea L.) supplementation in a mouse model of obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0232605 May 7, 2020 8 / 17
Discussion
In the present study, we found that lingonberry supplementation prevented high-fat diet
induced adverse effects on blood cholesterol, glucose and insulin levels as well as visceral fat
gain in a murine model of obesity. In addition, the circulating levels of the pro-inflammatory
adipocytokine leptin and the inflammatory acute phase reactant and biomarker serum amy-
loid A (SAA), as well as the alanine aminotransferase (ALT) activity were maintained at lower
level by lingonberry supplementation, and the same was detected in hepatic expression of the
inflammatory factors CXCL-14, S100A10 and SAA. To our knowledge, this is the first study in
which such significant results have been obtained with an air-dried lingonberry powder. The
results are remarkable also considering the rather short duration (6 weeks) of the study.
Obesity is a risk factor for glucose intolerance leading to diabetes, which is first detected as
increased circulating insulin concentrations followed by increased fasting blood glucose levels
[33,34]. In the present study, increased insulin and glucose levels were found already after six
weeks on high-fat diet. Lingonberry supplementation prevented these effects. These findings
are supported by previous studies with freeze-dried lingonberries and lingonberry extract on a
longer follow-up [21–23,25,35] while bilberry supplementation did not have any effect on
Fig 5. The insulin levels of mice at the end of the study. Animals received low-fat diet (LF diet, 10% energy from fat, grey column), high-fat diet (HF
diet, 46% energy from fat, black column) or high-fat diet supplemented with lingonberry (HF + LGB diet, white column). At the end of the study, blood
samples were collected after 6 h fasting and serum insulin concentrations were analyzed with ELISA. The results are expressed as pmol/L. Values
represent mean + SEM, n = 10 mice per group. One-way ANOVA with Bonferroni post-test was used in the statistical analysis. Differences between the
groups are marked with ��� p< 0.001.
https://doi.org/10.1371/journal.pone.0232605.g005
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blood glucose levels [36]. Anthocyanins in the lingonberry powder could contribute to the
beneficial effects on glucose tolerance as anthocyanin-rich supplements from Montmorency
tart cherries have been reported to have insulin lowering effects in patients with metabolic syn-
drome [37] and purified blueberry anthocyanins reduced blood glucose levels in a murine
model of obesity [38]. In the present study, lingonberry supplementation did not alter hepatic
expression of the glucose transporter GLUT2 or insulin receptor. Further studies are needed
to understand the mechanisms which mediate the positive effects of lingonberries on glucose
tolerance in obesity.
Hyperlipidemia is another characteristic feature of obesity associated metabolic syndrome
[4]. In the present study, lingonberry supplementation normalized the detrimental effects of
the high-fat diet on the cholesterol levels, and triglycerides were also reduced. Proanthocyani-
dins present in lingonberries may explain, at least partly, the favorable effects on cholesterol
levels [39–41]. In addition, the purified lingonberry anthocyanidin compound cyanidin-3-O-
Fig 6. Cholesterol (A) and triglyceride (B) levels of mice at the end of the study. Animals received low-fat diet (LF diet, 10% energy from fat, grey
columns), high-fat diet (HF diet, 46% energy from fat, black columns) or high-fat diet supplemented with lingonberry (HF + LGB diet, white columns).
At the end of the study, blood samples were collected after 6 h fasting and serum cholesterol and triglyceride concentrations were analyzed with
fluorometric assays. The values are presented as mmol/L. Values represent mean + SEM, n = 10 mice per group. One-way ANOVA with Bonferroni
post-test was used in the statistical analysis. Differences between the groups are marked with �p< 0.05, ��p< 0.01, ���p< 0.001 and ns = not
significant.
https://doi.org/10.1371/journal.pone.0232605.g006
Table 2. The circulating adipokine and serum amyloid A (SAA) levels, and alanine aminotransferase (ALT) activity of the mice at the end of the study.
Low-fat (LF) High-fat (HF) High-fat + lingonberry (HF+LGB) p-value between LF and HF p-value between HF and HF+LGB
Adiponectin (μg/mL) 6.9 ± 0.2 6.4 ± 0.2 7.1 ± 0.3 0.277 0.100
Leptin (ng/mL) 4.6 ± 0.6 39.7 ± 2.8 27.1 ± 3.5 < 0.001 < 0.01
Resistin (ng/mL) 17.8 ± 1.4 16.8 ± 0.8 17.6 ± 0.9 > 0.999 > 0.999
SAA (μg/mL) 6.6 ± 0.6 11.7 ± 0.7 7.4 ± 0.4 < 0.001 < 0.001
ALT (U/L) 8.1 ± 0.6 14.1 ± 0.8 7.2 ± 0.2 < 0.001 < 0.001
Adiponectin, leptin, resistin and SAA concentrations were measured by ELISA, and ALT activity by fluorometric assay. The results are presented as mean ± SEM; n = 10
mice per group. One-way ANOVA with Bonferroni post-test was used in the statistical analysis.
https://doi.org/10.1371/journal.pone.0232605.t002
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Fig 7. The expression of C-X-C motif chemokine ligand 14 (CXCL-14, A), S100 calcium-binding protein A10
(S100A10, B), serum amyloid A2 (SAA2, C), tumor necrosis alpha (TNF-α, D), interleukin 1β (IL-1β, E),
monocyte chemoattractant protein 1 (MCP-1, F), glucose transporter 2 (GLUT2, G), and insulin receptor (H) in
the liver. Animals received low-fat diet (LF diet, 10% energy from fat, grey columns), high-fat diet (HF diet, 46%
energy from fat, black columns) or high-fat diet supplemented with lingonberry (HF + LGB diet, white columns). At
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β-glucoside was found effective in decreasing total cholesterol levels in hypercholesterolemic
ApoE deficient mice [42]. Lingonberries are also known to contain plant sterols at moderate
levels of 20–30 mg/100 g of fresh weight [30,31] and they may contribute to the lipid lowering
effects of lingonberries [43]. The lipid lowering effect seems to be characteristic for lingonberry
among berries since freeze-dried blueberry and black raspberry [44] as well blackcurrant [21]
were reported to enhance serum lipids in high-fat diet fed mice, while our findings are sup-
ported by previous studies with lingonberry containing diets [21,35,45]. High-fat treatment
normally results in increased circulating triglycerides in humans [46], but in mice their levels
may stay unchanged or decrease [21,38,45,47–49], and the former was found also in the pres-
ent study. These effects on triglycerides may result from increased clearance of triglycerides
and/or reduced production of triglycerides in the liver [47–49]. Increased ALT activity in the
serum, as was also shown in the current study, supports the former assumption likewise associ-
ated with the development of nonalcoholic fatty liver disorder [50].
Adipokines are cytokine-like hormones originally found to be produced by adipose tissue
and to regulate energy metabolism and appetite [51,52]. Leptin is a prototype adipokine, the
concentrations of which are closely related to the amount of adipose tissue and body mass
index [53,54]. This is the first study showing reduced leptin levels during lingonberry supple-
mentation of high-fat diet but the results are supported by studies using blueberry anthocya-
nins [38,44]. It is not clear if this effect is simply a consequence of the moderate weight gain
restraining effect of lingonberry supplementation or whether it has mechanistic relevancy.
Anyhow, reduced leptin level may be considered as a beneficial effect because leptin has pro-
inflammatory effects and contributes to the development of co-morbidities of obesity [55]. In
addition, an increasing trend in adiponectin levels was seen in mice on lingonberry supple-
mented high-fat diet. Since adiponectin has insulin sensitizing effects [4], this is a positive sig-
nal and motivates further studies.
Obesity is associated with low-grade inflammation, which contributes to the obesity-related
metabolic diseases. Serum amyloid A (SAA) is an example of the biomarkers and effectors of
obesity-related inflammation, and it is involved in the mechanisms of lipid metabolism, ath-
erosclerosis and acute phase response besides inflammation [56,57]. In the present study, cir-
culating SAA concentrations, as well as its expression in the liver, were substantially increased
during high-fat diet while lingonberry supplementation prevented these changes in a statisti-
cally significant manner. In addition, lingonberry supplementation reduced the hepatic
expression of two other pro-inflammatory factors, i.e. the chemokine CXCL-14 and the S100
calcium-binding protein A10. These data indicate that lingonberry supplementation indeed
suppresses the obesity-related inflammatory response.
Based on the present data, it remains unclear, which factor(s) present in the lingonberry
powder may have caused the beneficial effects found in the current study, and further studies
are needed to reveal the active constituents. The effects of lingonberry supplementation on the
weight gain were moderate while it significantly prevented many of the metabolic and inflam-
matory adverse effects induced by the high-fat diet. Therefore, it is possible that lingonberry
supplementation in the high-fat containing diet has anti-inflammatory consequences and
shifts endogenous responses towards metabolically healthier obesity. Lingonberries contain
the end of the study, liver samples were collected after 6 h fasting and the expression of the genes of interest were
measured with RT-PCR. After normalizing to the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), the expression level in each sample was compared to the mean expression level in the LF-group, which was
set as 1. One-way ANOVA with Bonferroni post-test was used in the statistical analysis. Differences between the
groups are marked with �p< 0.05, ��p< 0.01 and ���p< 0.001.
https://doi.org/10.1371/journal.pone.0232605.g007
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several polyphenolic compounds, which have anti-inflammatory potential such as anthocya-
nins, ellagitannins, flavonols, phenolic acids and proanthocyanidins [58], flavonols and
proanthocyanidins as well as anthocyanins forming the largest groups among the lingonberry
polyphenols [58–62].
Quercetin is abundantly present in lingonberries [63]. Quercetin has been reported to have
anti-inflammatory effects in in vitro and in vivo models [64–66]. Moreover, quercetin has also
been suggested to have anti-adiposity activity in vitro by activating the AMPK signal pathway
in adipocytes [67] and in vivo by preventing high-fat diet induced obesity in mice [68]. Lingon-
berries are also a rich source of proanthocyanidins [60,69] and anthocyanins, particularly cya-
nidin-3-galactoside, cyanidin-3-arabinoside, and cyanidin-3-glucoside [70,71].
Proanthocyanidins have been reported to contribute to the reduced weight gain and hypolipi-
demic effects of berry-derived preparations in animal models of obesity [40,72,73] while puri-
fied anthocyanins from mulberry (M. australis P.) and cherry (Prunus avium L.) prevented
obesogenic diet induced weight gain, oxidative stress and inflammation in mice [74,75]. Ling-
onberry contains also the stilbenoid compound resveratrol (together with its glycosylated
derivative piceid), which is a strong antioxidant with anti-inflammatory properties [76–78].
We have recently shown that resveratrol inhibits the production of nitric oxide and pro-
inflammatory cytokines in activated macrophages and suppresses inflammatory responses in
vivo [79]. Resveratrol has also been beneficial in animal models of obesity [80–82], and in a
clinical study resveratrol supplementation improved glycemic control in patients with type 2
diabetes [83].
In conclusion, the present results show that lingonberry supplementation significantly pre-
vents high-fat diet induced metabolic and inflammatory changes in a murine model of obesity.
Further studies are needed to reveal the detailed molecular mechanisms and the active constit-
uents responsible for the observed beneficial effects. The results encourage evaluation of ling-
onberries as a part of healthy diet against obesity and its comorbidities.
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